Home arrow Conferences arrow Details


Quick links to our categories
Engineering and Technology   Business and Economics
Physical and life sciences   Regional Studies
Health and Medicine   Education
Interpersonal   Mathematics and statistics
 
  | Print |
Conferences - Details

Conference
when: 27 Sep 2010 - 28 Sep 2010  
Title Pharmaceutical Co-Crystals 2010
Where: Movenpick Hotel, Amsterdam City Centre - Amsterdam
Category: Health and Medicine
 
Conference description:
Pharmaceutical Co-Crystals 2010
27 - 28 September, 2010, Mövenpick Hotel Amsterdam City Centre

E.: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
T.: +44(0)20 7368 9300
Web - http://www.pharmacocrystals.com

Event only price: 1899 EUR
Register by 18th June and receive up to €500 off!

Realising the Commercial Potential of Implementing Pharmaceutical Co-Crystals into Your R&D Strategy

Pharmaceutical Co-Crystals are now being recognised as an attractive alternative route for solid state development. Through integration of a co-former partner into the crystal lattice, it is possible to manipulate the physico-chemical characteristics of the API thus enhancing properties such as solubility, dissolution rate, stability and bioavailability, which are integral to the effectiveness and success of future medicines. At present, achieving scale up of co-crystal production while maintaining the physico-chemical advantages which they afford is a major challenge in the pharmaceutical arena.

For that reason, Pharmaceutical Co-Crystals 2010 will explore the results and knowledge acquired over the years on perfecting the art of co-crystal formation and how best to apply it at both the laboratory and manufacturing scale, with the ultimate aim of realising the commercial potential of co-crystals in pharmaceutical drugs.

The Expert Speaker Panel includes:

     Dr B N Roy, Head of Research & Development, Lupin Pharmaceuticals
     Dr Peter Karpinski, Senior Principal Fellow, Novartis
     Dr Simon Black, Principal Scientist, AstraZeneca
     Associate Professor Nair Rodriguez-Hornedo, Department of Pharmaceutical Sciences, University of Michigan
     Mr Bertrand Gellie, Director, The European Patent Office (EPO)
     Dr Yaling Wang, Research Fellow, Merck
     Dr Jeffrey Lindeman, J.A. Lindeman & Co. PLLC
     Dr David Berry, Senior Scientist, Solid-State Development, AstraZeneca
 
Language: English
Organization: Pharma IQ
Contact person: Rosa Cortez
Email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Internet address: http://www.pharmacocrystals.com
 
Location
Venue Movenpick Hotel, Amsterdam City Centre
City Amsterdam
Country: NL

 

Home  |  Legal notice  |  Sitemap  |  Terms and Conditions